Verano Holdings (VRNO) Goodwill (2021 - 2026)
Verano Holdings' (VRNO) quarterly Goodwill came in at $161.0 million in Q1 2026, down 34.97% year-on-year from $247.6 million in Q1 2025, and little changed on a QoQ basis from $161.0 million in Q4 2025.
Verano Holdings (VRNO) Goodwill (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has 6 years of Goodwill data on file, last reported at $161.0 million in Q1 2026.
- On a quarterly basis, Goodwill fell 34.97% year-over-year to $161.0 million in Q1 2026; TTM through Mar 2026 was $161.0 million, a 34.97% decrease from a year earlier, with the FY2025 full-year figure at $161.0 million, down 34.61% from the prior year.
- Goodwill for Q1 2026 stood at $161.0 million, roughly flat from $161.0 million in the prior quarter.
- Over the last five years, Goodwill for VRNO reached as high as $380.4 million in Q3 2022 and fell as low as $161.0 million in Q4 2025.
- Historically, Goodwill has averaged $255.7 million across 5 years, with a median of $247.6 million in 2025.
- Across the five-year window, Goodwill surged 31.27% in 2022 and plunged 34.97% in 2026, its largest moves.
- Year by year, Goodwill stood at $269.1 million in 2022, then retreated by 14.05% to $231.3 million in 2023, then increased by 6.46% to $246.2 million in 2024, then sank by 34.61% to $161.0 million in 2025, then changed by 0.0% to $161.0 million in 2026.
- Per Business Quant data, the three most recent Goodwill figures were $161.0 million in Q1 2026, $161.0 million in Q4 2025, and $247.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Verano Holdings | 2.02 Bn | 1.94 Bn | 98.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 161.01 Mn |
| Dec 31, 2025 | 161.01 Mn |
| Sep 30, 2025 | 247.60 Mn |
| Jun 30, 2025 | 247.60 Mn |
| Mar 31, 2025 | 247.60 Mn |
| Dec 31, 2024 | 246.23 Mn |
| Sep 30, 2024 | 252.18 Mn |
| Jun 30, 2024 | 231.29 Mn |
| Mar 31, 2024 | 231.29 Mn |
| Dec 31, 2023 | 231.29 Mn |
| Sep 30, 2023 | 269.22 Mn |
| Jun 30, 2023 | 269.28 Mn |
| Mar 31, 2023 | 269.09 Mn |
| Dec 31, 2022 | 269.09 Mn |
| Sep 30, 2022 | 380.41 Mn |
| Jun 30, 2022 | 376.64 Mn |
| Dec 31, 2021 | 368.13 Mn |
| Sep 30, 2021 | 289.79 Mn |
| Jun 30, 2021 | 379.70 Mn |